Metabolic effects of adding Topiramate on Aripiprazole in bipolar patients under age 18

Phase 3

Recruiting

• Conditions: Condition 1: Bipolar disorder. Condition 2: Metabolic syndrome.; Bipolar affective disorder; Nutritional and metabolic disorders in diseases classified elsewhere

• Registration Number: IRCT20200606047668N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 38

Inclusion Criteria

Consent to participate in the study by completing the informed consent form by patient and family.
Lack of any chronic physical illness.
Negative history of recieving any antypsychotic drug or mood stabilizers or drugs that could change appetite during recent 3 month before study
Lack of history of allergic reaction to topiramate
Lack of history of renal insufficiency or renal stone
Age between 6-18 years

Exclusion Criteria

patient or family unwillingness to stay in study
Need to ECT treatment during study
Any unexpected new physical illness that could change medical care of patient

Study & Design

• Study Type: interventional
• Study Design: Not specified